Complications after cochlear implantation in adult patients. 10-Year retrospective analysis of a tertiary academic centre
Complications after cochlear implantation in adult patients. 10-Year retrospective analysis of a tertiary academic centre
复制标题
DOI：
10.1016/j.an1.2016.03.012
复制
发表时间：
2017-02-01
影响因子：
1.7
通讯作者：
Lorenzo Lorenzo, Ana Isabel
中科院分区：
文献类型：
--
作者：
Chiesa Estomba, Carlos Miguel;Schmitz, Teresa Rivera;Lorenzo Lorenzo, Ana Isabel
目的：人工耳蜗植入体（CI）是一种电子设备，能够实现听觉康复和管理重度至极重度双侧听力损失的个体，如今，高龄并不被认为是人工耳蜗植入的禁忌症，一些研究表明，老年人确实受益于CI，听力和生活质量得到改善。方法：回顾性分析在三级学术中心接受人工耳蜗植入手术的18岁以上患者。结果：57例患者符合纳入标准：男性25例（43.9%），女性32例（56.1%）。轻微并发症占24.6%，严重并发症占17.5%。在我们的系列中，最常见的轻微并发症是前庭障碍，最常见的严重并发症是器械失效。未发现年龄、既往脑膜炎史、解剖学变量或合并症与并发症之间存在相关性。结论：耳蜗植入术是一种安全的重度至极重度感音神经性聋康复手术。根据我们的研究结果，年龄超过65岁或合并症的存在对我们患者的并发症发生率没有直接影响。(C)2016爱思唯尔爱尔兰有限公司版权所有。
Objective: Cochlear implants (CI) are electronic devices that enable the auditory rehabilitation and the management of individuals with severe to profound bilateral hearing loss, and nowadays, advanced age is not considered a contraindication for cochlear implantation and several studies have shown that older adults do benefit from CI, with improvements in hearing abilities and quality of life. Methods: Retrospective analysis of patients older than 18 years who underwent cochlear implant surgery in a tertiary academic centre. Results: 57 patients met the inclusion criteria: 25 (43.9%) male and 32 (56.1%) female. Total percentage of minor complication was 24.6% and major complication was 17.5%. The most common minor complication in our series was vestibular disorder, and the most common major complication was device failure. No correlation was found among age, previous meningitis, anatomical variables or comorbidities with the appearance of complications. Conclusion: Cochlear implantation is a safe surgical technique for rehabilitation of severe to profound sensorineural hearing loss. According to our results, neither the age over 65 years nor the presence of comorbidities does have a direct impact over the complication rates in our patients. (C) 2016 Elsevier Ireland Ltd. All rights reserved.